Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

Cited In for PubMed (Select 17082969)


Neuronal reorganization in adult rats neonatally exposed to (±)-3,4-methylenedioxymethamphetamine.

Williams MT, Skelton MR, Longacre ID, Huggins KN, Maple AM, Vorhees CV, Brown RW.

Toxicol Rep. 2014;1:699-706.


Acute Effects of Ecstasy on Memory Are more Extensive than Chronic Effects.

Shariati MB, Sohrabi M, Shahidi S, Nikkhah A, Mirzaei F, Medizadeh M, Asl SS.

Basic Clin Neurosci. 2014 Summer;5(3):225-30.


3,4-methylenedioxymethamphetamine (MDMA): current perspectives.

Meyer JS.

Subst Abuse Rehabil. 2013 Nov 21;4:83-99. doi: 10.2147/SAR.S37258. eCollection 2013. Review.


MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology.

Sáez-Briones P, Hernández A.

Curr Neuropharmacol. 2013 Sep;11(5):521-34. doi: 10.2174/1570159X11311050007.


Verbal memory deficits are correlated with prefrontal hypometabolism in (18)FDG PET of recreational MDMA users.

Bosch OG, Wagner M, Jessen F, Kühn KU, Joe A, Seifritz E, Maier W, Biersack HJ, Quednow BB.

PLoS One. 2013 Apr 9;8(4):e61234. doi: 10.1371/journal.pone.0061234. Print 2013.


MDMA 'ecstasy' increases cerebral cortical perfusion determined by bolus-tracking arterial spin labelling (btASL) MRI.

Rouine J, Gobbo OL, Campbell M, Gigliucci V, Ogden I, McHugh Smith K, Duffy P, Behan B, Byrne D, Kelly ME, Blau CW, Kerskens CM, Harkin A.

Br J Pharmacol. 2013 Jul;169(5):974-87. doi: 10.1111/bph.12178.


Effects of a short-course MDMA binge on dopamine transporter binding and on levels of dopamine and its metabolites in adult male rats.

Biezonski DK, Piper BJ, Shinday NM, Kim PJ, Ali SF, Meyer JS.

Eur J Pharmacol. 2013 Feb 15;701(1-3):176-80. doi: 10.1016/j.ejphar.2012.12.024. Epub 2012 Dec 28.


Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.

Watkins TJ, Raj V, Lee J, Dietrich MS, Cao A, Blackford JU, Salomon RM, Park S, Benningfield MM, Di Iorio CR, Cowan RL.

Psychopharmacology (Berl). 2013 May;227(1):41-54. doi: 10.1007/s00213-012-2936-1. Epub 2012 Dec 16.


Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.

Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B, Michel Y, Brewerton TD, Doblin R.

J Psychopharmacol. 2013 Jan;27(1):28-39. doi: 10.1177/0269881112456611. Epub 2012 Nov 20.


Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.

Di Iorio CR, Watkins TJ, Dietrich MS, Cao A, Blackford JU, Rogers B, Ansari MS, Baldwin RM, Li R, Kessler RM, Salomon RM, Benningfield M, Cowan RL.

Arch Gen Psychiatry. 2012 Apr;69(4):399-409. doi: 10.1001/archgenpsychiatry.2011.156. Epub 2011 Dec 5.


The influence of genetic and environmental factors among MDMA users in cognitive performance.

Cuyàs E, Verdejo-García A, Fagundo AB, Khymenets O, Rodríguez J, Cuenca A, de Sola Llopis S, Langohr K, Peña-Casanova J, Torrens M, Martín-Santos R, Farré M, de la Torre R.

PLoS One. 2011;6(11):e27206. doi: 10.1371/journal.pone.0027206. Epub 2011 Nov 16.


Prospective memory deficits in Ecstasy users: effects of longer ongoing task delay interval.

Weinborn M, Woods SP, Nulsen C, Park K.

J Clin Exp Neuropsychol. 2011 Dec;33(10):1119-28. doi: 10.1080/13803395.2011.614595. Epub 2011 Nov 3.


Effects of exposure to amphetamine derivatives on passive avoidance performance and the central levels of monoamines and their metabolites in mice: correlations between behavior and neurochemistry.

Murnane KS, Perrine SA, Finton BJ, Galloway MP, Howell LL, Fantegrossi WE.

Psychopharmacology (Berl). 2012 Apr;220(3):495-508. doi: 10.1007/s00213-011-2504-0. Epub 2011 Oct 13.


MDMA (ecstasy) effects on actual driving performance before and after sleep deprivation, as function of dose and concentration in blood and oral fluid.

Bosker WM, Kuypers KP, Conen S, Kauert GF, Toennes SW, Skopp G, Ramaekers JG.

Psychopharmacology (Berl). 2012 Aug;222(3):367-76. doi: 10.1007/s00213-011-2497-8. Epub 2011 Sep 28.


Human Ecstasy use is associated with increased cortical excitability: an fMRI study.

Bauernfeind AL, Dietrich MS, Blackford JU, Charboneau EJ, Lillevig JG, Cannistraci CJ, Woodward ND, Cao A, Watkins T, Di Iorio CR, Cascio C, Salomon RM, Cowan RL.

Neuropsychopharmacology. 2011 May;36(6):1127-41. doi: 10.1038/npp.2010.244. Epub 2011 Feb 16.


Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs.

Halpern JH, Sherwood AR, Hudson JI, Gruber S, Kozin D, Pope HG Jr.

Addiction. 2011 Apr;106(4):777-86. doi: 10.1111/j.1360-0443.2010.03252.x. Epub 2011 Feb 15.


Developmental cascades: linking adolescent substance use, affiliation with substance use promoting peers, and academic achievement to adult substance use disorders.

Haller M, Handley E, Chassin L, Bountress K.

Dev Psychopathol. 2010 Nov;22(4):899-916. doi: 10.1017/S0954579410000532.


Comparison of (+)-methamphetamine, ±-methylenedioxymethamphetamine, (+)-amphetamine and ±-fenfluramine in rats on egocentric learning in the Cincinnati water maze.

Vorhees CV, He E, Skelton MR, Graham DL, Schaefer TL, Grace CE, Braun AA, Amos-Kroohs R, Williams MT.

Synapse. 2011 May;65(5):368-78. doi: 10.1002/syn.20854. Epub 2010 Oct 8.


Dose-related effects of MDMA on psychomotor function and mood before, during, and after a night of sleep loss.

Bosker WM, Kuypers KP, Conen S, Ramaekers JG.

Psychopharmacology (Berl). 2010 Mar;209(1):69-76. doi: 10.1007/s00213-009-1767-1.


Sleep apnea in young abstinent recreational MDMA ("ecstasy") consumers.

McCann UD, Sgambati FP, Schwartz AR, Ricaurte GA.

Neurology. 2009 Dec 8;73(23):2011-7. doi: 10.1212/WNL.0b013e3181c51a62. Epub 2009 Dec 2.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk